Ocular adverse events associated with immune checkpoint inhibitors, a scoping review
Abstract Introduction Immune checkpoint inhibitors (ICIs) have become an important part of the treatment of multiple cancers, especially for advanced melanoma and non-small cell lung cancer. Some tumors are capable of escaping immunosurveillance by stimulating checkpoints on T-cells. ICIs prevent ac...
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
SpringerOpen
2023-02-01
|
| シリーズ: | Journal of Ophthalmic Inflammation and Infection |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s12348-022-00321-2 |